Landscapes / Companies
Kedrion S.p.A. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
4 active
9 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Primary Immunodeficiency Disease, Chronic Inflammatory Demyelinating Polyneuropathy and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- Coagadex, Human Plasminogen, Kedbumin 25%
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021